ClinConnect ClinConnect Logo
Search / Trial NCT05613712

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Launched by UNIVERSITY HOSPITAL, GRENOBLE · Nov 4, 2022

Trial Information

Current as of July 06, 2025

Unknown status

Keywords

Rheumatoid Arthritis Spondyloarthropathy Spondylarthritis Ankylosing Spondylitis Psoriatic Arthritis Chronic Inflammatory Rheumatic Diseases Comorbidities Continuity Of Patient Care Patient Compliance Adherence Non Adherence

ClinConnect Summary

This clinical trial, titled "Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine," is looking into how to better manage chronic inflammatory diseases like rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. The goal is to identify what factors might prevent patients from following the treatment recommendations provided by their doctors. This research is being conducted at the CHU Grenoble Alpes hospital, and they are currently recruiting participants.

To be eligible for this study, participants need to be adults over 18 years old who have been treated for one of the specified conditions and have been hospitalized in the rheumatology department. Both patients and their referring physicians can participate in the study, but certain individuals, such as those with severe psychiatric issues or minors, are excluded. If you join this study, you can expect to help researchers understand better ways to support patients in following their treatment plans, ultimately aiming to improve health outcomes for those living with chronic inflammatory diseases.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patient cohort :
  • men and women over 18 years of age
  • Informed volunteers who have consented to participate in the study
  • have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
  • have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
  • * Cohort of referring physicians :
  • volunteers who received informed information and consented to participate in the study
  • be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes
  • Exclusion Criteria:
  • * Patient cohort :
  • psychiatric pathologies or history of behavioural disorders
  • persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
  • persons under guardianship or curatorship
  • not affiliated to the social security system
  • minors
  • Refusal to participate by the patient and/or unreturned questionnaire
  • * Cohort of referring physicians:
  • the physician is no longer the patient's referring physician
  • refusal of the doctor to participate and/or questionnaire not returned

About University Hospital, Grenoble

The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.

Locations

Grenoble, , France

Grenoble, , France

Grenoble, Grenoble Cedex 9, France

Patients applied

0 patients applied

Trial Officials

Xavier ROMAND, PHD

Principal Investigator

CHU Grenoble Alpes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials